NCT06597539 is a clinical trial in Hepatobiliary Malignancy, sponsored by Ruijin Hospital.

Who is sponsoring NCT06597539?

NCT06597539 is sponsored by Ruijin Hospital.

What condition does NCT06597539 study?

NCT06597539 studies Hepatobiliary Malignancy.

Is NCT06597539 still recruiting?

NCT06597539 is currently recruiting now. Last updated 11 December 2024.

Last reviewed 2024-12-11 · How we verify

NCT06597539

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy

Recruiting now Last updated 11 December 2024

What this trial tests

trial in Hepatobiliary Malignancy in 40 participants. Currently enrolling.

Timeline

9 November 2024

Primary endpoint
30 June 2026

31 July 2027

Quick facts

Lead sponsor	Ruijin Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	40
Start date	9 November 2024
Primary completion	30 June 2026
Estimated completion	31 July 2027
Sites	1 location across China

Conditions studied

Hepatobiliary Malignancy — all drugs for Hepatobiliary Malignancy →

Sponsor

Ruijin Hospital

Who can join

Adults 18 to 75, any sex, with Hepatobiliary Malignancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the value of 68Ga-grazytracer in predicting the efficacy of immunotherapy for advanced hepatobiliary malignancies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hepatobiliary Malignancy

Currently open trials in the same condition.

NCT07174947 — SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depre · Phase 2 · recruiting

Other Ruijin Hospital trials

Trials by the same sponsor.

NCT07589361 — Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors · not yet recruiting
NCT07449507 — Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy · NA · not yet recruiting
NCT07496385 — Clinical Study on the Efficacy of Subglottic Suction in Mechanically Ventilated Patients Guided by Bedside Ultrasound · NA · not yet recruiting
NCT07511114 — A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyp · Phase 3 · not yet recruiting
NCT07514169 — The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06597539 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ruijin Hospital
Last refreshed: 11 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06597539.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing